Journals / Biotech Studies / 2022 / Cilt: 31 - Sayı: 2

Health promoting benefits of postbiotics produced by lactic acid bacteria: Exopolysaccharide

Pages
61–70
Publication Date
2022-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, it is presented a comprehensive overview for the most recent reports on the health benefits of postbiotic lactic acid bacterial exopolysaccharides.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Exopolysaccharides are high molecular weight polymers of repeated sugar units with diverse chemical structure and unique properties and produced by microorganisms.
📊
Key Findings & Data:Lactic acid bacteria are important exopolysaccharide producers.
💡
Conclusion & Impact:In this review, it is presented a comprehensive overview for the most recent reports on the health benefits of postbiotic lactic acid bacterial exopolysaccharides.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Lactic acid bacteria · Exopolysaccharides · Bioactivities

Abstract

Exopolysaccharides are high molecular weight polymers of repeated sugar units with diverse chemical structure and unique properties and produced by microorganisms. Lactic acid bacteria are important exopolysaccharide producers. Lactic acid bacteria derived exopolysaccharides, one of the postbiotics, are known to have technological properties such as stabilizing, thickening, emulsifing and also biological activities. Lactic acid bacteria can synthesis exopolysaccharides with large structural variability and this diversity brings these polymers to possess several bioactivities. Bioactivities such as immunomodulatory, antiinflammatory, antitumor and antimutagenicity, antioxidant, antibacterial and antiviral, cholesterol-lowering, antihypertensive activity and gastro-protective activity bring these biopolymers commercial value in the global market and potential to be used in biomedical and pharmaceutical applications. Therefore, to evaluate the availability of these natural exopolysaccharides for new applications extensive understanding of the structure-function relationships will be required. In this review, it is presented a comprehensive overview for the most recent reports on the health benefits of postbiotic lactic acid bacterial exopolysaccharides.

🔖

Cite This Article

GEZGİNÇ, Y., KARABEKMEZ-ERDEM, T., TATAR, H. D., AYMAN, S., GANİYUSUFOĞLU, E., DAYISOYLU, K. S. (2022). Health promoting benefits of postbiotics produced by lactic acid bacteria: Exopolysaccharide. Biotech Studies, Cilt: 31 - Sayı: 2, 61–70. https://ajindex.com/articles/858195

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Abbasi, A., Rad, A. H., Ghasempour, Z., Sabahi, S., Kafil, H. S., Hasannezhad, P., Saadat, Y. R., & Shahbazi, N. (2021). The biological activities of postbiotics in gastrointestinal disorders. Critical Reviews in Food Science and Nutrition, 1-22. https:// doi.org/10.1080/10408398.2021.1895061 Adebayo-Tayo, B., & Fashogbon, R. (2020). In vitro antioxidant, antibacterial, in vivo immunomodulatory, antitumor and hematological potential of exopolysaccharide produced by wild type and mutant Lactobacillus delbureckii subsp.bulgaricus. Heliyon, 6(2), 1-10. https://doi.org/10.1016/j.heliyon.2020.e03268
  2. Adebayo-Tayo, B., Ishola, R., & Oyewunmi, T. (2018). Characterization, antioxidant and immunomodulatory potential on exopolysaccharide produced by wild type and mutant Weissella confusa strains. Biotechnology Reports, 19, e00271. https://doi.org/10.1016/j.btre.2018.e00271
  3. Adesulu-Dahunsi, A. T., Sanni, A. I., Jeyaram, K., Ojediran, J. O., Ogunsakin, A. O., & Banwo, K. (2018). Extracellular polysaccharide from Weissella confusa OF126: Production, optimization, and characterization. International Journal of Biological Macromolecules, 111, 514-525. https://doi.org/10.1016/j.ijbiomac.2018.01.060
  4. Alsaadi, L. G., Baker, B. A. A., Kadhem, B. M., Mahdi, L. H., & Mater, H. N. (2020). Exopolysaccharide as antiviral, antimicrobial and as immunostimulants: A review. Plant Archives, 20(2), 5859-5875. eISSN: 2581-6063.
  5. Angelin, J., & Kavitha, M. (2020). Exopolysaccharides from probiotic bacteria and their health potential. International Journal of Biological Macromolecules, 162, 853-865. https://doi.org/10.1016/j.ijbiomac.2020.06.190
  6. Buddana, S. K., Venkata Naga Varanasi, Y., & Reddy Shetty, P. (2015). Fibrinolytic, antiinflammatory and antimicrobial properties of α-(1-3)-glucans produced from Streptococcus mutans (MTCC 497). Carbohydrate Polymers, 15, 152–159. https://doi.org/10.1016/j.carbpol.2014.08.083
  7. Castro-Bravo, N., Wells, J. M., Margolles, A., & Ruas-Madiedo, P. (2018). Interactions of surface exopolysaccharides from Bifidobacterium and Lactobacillus within the intestinal environment. Front in Microbiology, 9, 2426, 1-15. https://doi.org/10.3389/fmicb.2018.02426
  8. Chaisuwan, W., Jantanasakulwong, K., Wangtueai, S., Phimolsiripol, Y., Chaiyaso, T., Techapun, C., Phongthai, S., You, S., Regenstein, J. M., & Seesuriyachan, P. (2020). Microbial exopolysaccharides for immune enhancement: Fermentation, modifications and bioactivities, Food Bioscience, 35, 1-17. https://doi.org/1